10-Q: Mag Magna Corp. Reports Q3 2024 Results: Revenue Growth Offset by Net Loss

Sentiment:

Quarterly Report


Mag Magna Corp. reports revenue growth for the three and nine months ended January 31, 2024, but also reports a net loss and identifies material weaknesses in internal controls.

Capital raiseThe company intends to finance operating costs with public issuance of common stock.During February 2024 the Company issued 270,400 shares of common stock for cash proceeds of $6,760 at $0.025 per share.During March 2024 the Company issued 135,200 shares of common stock for cash proceeds of $3,380 at $0.025 per share.
Worse than expectedThe company reported a net loss and identified material weaknesses in internal controls, indicating worse than expected performance.

Summary

  • Mag Magna Corp., a Wyoming-based company focused on poultry farming and antibiotic-free feed additives, filed its Form 10-Q for the quarter ended January 31, 2024.
  • The company generated revenue of $4,200 for the three months ended January 31, 2024, and $5,600 for the nine months ended the same date.
  • Operating expenses totaled $6,284 for the quarter and $20,780 for the nine-month period.
  • The company reported a net loss of $2,078 for the quarter and $15,163 for the nine-month period.
  • As of January 31, 2024, the company had cash and cash equivalents of $11,535.
  • The company acknowledges substantial doubt about its ability to continue as a going concern due to an accumulated deficit of $33,080 and net cash used in operating activities.
  • Management intends to finance operating costs with existing cash and public issuance of common stock.
  • The company identifies material weaknesses in its internal control over financial reporting, including a lack of adequate internal control structure and segregation of duties.
  • Subsequent to the quarter, the company issued additional shares of common stock in February and March 2024 for cash proceeds.
  • The company is focused on distributing, marketing, and selling a methodology of developed formulas for feed additives utilizing advanced technologies.

Sentiment

Score: 4

Explanation: The sentiment is neutral to slightly negative due to revenue generation being offset by net losses, concerns about going concern status, and identified material weaknesses in internal controls. However, there are positive aspects such as increased cash and a strategic partnership.

Positives

  • The company generated revenue of $4,200 for the three months ended January 31, 2024, and $5,600 for the nine months ended the same date.
  • Cash and cash equivalents increased from $4,513 as of April 30, 2023, to $11,535 as of January 31, 2024.
  • The company has established a long-term partnership agreement with Ipax LLC to distribute, market, and sell a methodology of the developed formula of feed additives that strengthens the immunity of poultry in the U.S. market.
  • The company received the notice of effectiveness from the Securities Exchange Commission on October 23, 2023.

Negatives

  • The company reported a net loss of $2,078 for the quarter and $15,163 for the nine-month period.
  • The company acknowledges substantial doubt about its ability to continue as a going concern due to an accumulated deficit of $33,080.
  • The company identifies material weaknesses in its internal control over financial reporting, including a lack of adequate internal control structure and segregation of duties.
  • The company has only one employee, which raises concerns about segregation of duties and adequate accounting resources.

Risks

  • The company's ability to continue as a going concern is dependent on generating profitable operations and/or obtaining necessary financing.
  • Material weaknesses in internal control over financial reporting could lead to misstatements in financial statements.
  • The company's reliance on a single employee poses a risk to operational continuity and internal controls.
  • The company's success depends on the market acceptance of its methodology for antibiotic-free poultry farming.

Future Outlook

Management intends to finance operating costs over the next twelve months with existing cash on hand and public issuance of common stock.

Management Comments

  • Management believes that they will be successful in obtaining the necessary financing and generating revenue to fund operations, meet regulatory requirements, and achieve commercial goals.
  • Management concluded that the company did not maintain effective internal control over financial reporting as of January 31, 2024, based on criteria established in Internal ControlIntegrated Framework issued by COSO.

Industry Context

The company operates in the poultry farming industry, focusing on antibiotic-free feed additives, which aligns with the growing consumer demand for healthier and more sustainable food production practices.

Comparison to Industry Standards

  • It is difficult to compare Mag Magna Corp.'s results to industry standards due to its early stage and unique focus on a specific methodology for antibiotic-free poultry farming.
  • Larger, established players in the animal feed and poultry industries, such as Cargill, ADM, and Tyson Foods, have significantly greater resources and market presence.
  • However, the trend towards antibiotic-free poultry production is gaining momentum, and companies like Perdue Farms have made significant strides in reducing antibiotic use, indicating a potential market opportunity for Mag Magna Corp.'s products.
  • The company's success will depend on its ability to effectively market and distribute its methodology and demonstrate its value proposition to poultry farmers.

Related Party Transactions

  • As of January 31, 2024, a director of the Company advanced $46,675 to the Company. This loan is unsecured, interest-free, with no fixed payment term, for working capital purposes.

Stakeholder Impact

  • Shareholders face the risk of dilution due to potential future equity issuances.
  • Employees (currently only one) face job security risks due to the company's going concern uncertainty.
  • Customers (poultry farmers) could benefit from the company's antibiotic-free feed additive methodology, but also face risks if the company fails to deliver on its promises.
  • Creditors face increased risk due to the company's going concern uncertainty.

Next Steps

  • The company intends to continue distributing, marketing, and selling its methodology for antibiotic-free feed additives.
  • Management intends to finance operating costs with existing cash and public issuance of common stock.
  • The company needs to address the identified material weaknesses in its internal control over financial reporting.

Key Dates

DateDescription
2021-09-20Date of incorporation of MAG MAGNA CORP. in Wyoming, U.S.
2021-11-26The Company issued 4,500,000 shares of its common stock at $0.001 per share for total proceeds of $4,500.
2023-10-23The Company received the notice of effectiveness from the Securities Exchange Commission.
2024-01-31End of the quarterly period for this report.
2024-03-08Date of report filing, with 5,656,647 common shares issued and outstanding.

Keywords

feed additives, poultry farming, financial statements, internal control, revenue, net loss, MAGA, CHASIS, going concern

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.